Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CBLL · against 470 other Healthcare companies of similar size
Ranked #324 of 471 · scores higher than 10% of peers
Bars: peers in each 10-point band of the valuation score148 peers with a valuation score of 0–9, including CBLL · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | CBLL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 460 reported | -6.2% | 1.3% | 25% | 30% | |
| EBITDA yieldHigher is better · 476 reported | -7.0% | 4.2% | 20% | 50% | |
| Free cash flow yieldHigher is better · 202 reported | -5.0% | -2.4% | 41% | 20% | |
| Book yieldHigher is better · 466 reported | 11.9% | 41.3% | 12% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 324 | 815M USD | 8 | 53 | |
| 324 | 593M USD | 8 | 40 | |
| 324 | 1.7B USD | 8 | 30 | |
| 324 | 675M USD | 8 | ||
| 324 | 1.1B USD | 8 | 50 | |
| 324 | 968M USD | 8 | 37 | |
| 324 | 560M USD | 8 | 42 | |
| 324 | 1.2B USD | 8 | ||
| 324 | 827M USD | 8 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score